ITRM20050422A1 - Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico. - Google Patents

Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico.

Info

Publication number
ITRM20050422A1
ITRM20050422A1 IT000422A ITRM20050422A ITRM20050422A1 IT RM20050422 A1 ITRM20050422 A1 IT RM20050422A1 IT 000422 A IT000422 A IT 000422A IT RM20050422 A ITRM20050422 A IT RM20050422A IT RM20050422 A1 ITRM20050422 A1 IT RM20050422A1
Authority
IT
Italy
Prior art keywords
medical field
dermonecrotizzanti
bacterial origin
protein factors
related uses
Prior art date
Application number
IT000422A
Other languages
English (en)
Inventor
Alessia Fabbri
Loredana Falzano
Carla Fiorentini
Siro Luvisetto
Walter Malorni
Sara Marinelli
Flaminia Pavone
Elisabetta Straface
Original Assignee
Consiglio Nazionale Ricerche
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche, Ist Superiore Sanita filed Critical Consiglio Nazionale Ricerche
Priority to IT000422A priority Critical patent/ITRM20050422A1/it
Priority to PCT/IT2006/000596 priority patent/WO2007017914A2/en
Priority to DE602006016952T priority patent/DE602006016952D1/de
Priority to EP06796248A priority patent/EP1909816B1/en
Priority to AT06796248T priority patent/ATE481107T1/de
Publication of ITRM20050422A1 publication Critical patent/ITRM20050422A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT000422A 2005-08-05 2005-08-05 Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico. ITRM20050422A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000422A ITRM20050422A1 (it) 2005-08-05 2005-08-05 Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico.
PCT/IT2006/000596 WO2007017914A2 (en) 2005-08-05 2006-08-03 Dermonecrotizing protein factors of bacterial origin and related uses in medical field
DE602006016952T DE602006016952D1 (de) 2005-08-05 2006-08-03 Cnf1 bacterielles toxin-protein aus e. coli als analgetikum
EP06796248A EP1909816B1 (en) 2005-08-05 2006-08-03 Cnf1 bacterial toxin protein from e. coli as analgesic
AT06796248T ATE481107T1 (de) 2005-08-05 2006-08-03 Cnf1 bacterielles toxin-protein aus e. coli als analgetikum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000422A ITRM20050422A1 (it) 2005-08-05 2005-08-05 Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico.

Publications (1)

Publication Number Publication Date
ITRM20050422A1 true ITRM20050422A1 (it) 2007-02-06

Family

ID=37663127

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000422A ITRM20050422A1 (it) 2005-08-05 2005-08-05 Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico.

Country Status (5)

Country Link
EP (1) EP1909816B1 (it)
AT (1) ATE481107T1 (it)
DE (1) DE602006016952D1 (it)
IT (1) ITRM20050422A1 (it)
WO (1) WO2007017914A2 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1398191B1 (it) * 2010-02-17 2013-02-14 Ist Superiore Sanita Uso di tossine che attivano le rho gtpasi per il trattamento e/o la prevenzione della sintomatologia associata alla sindrome di rett (rtt).

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1420783A (zh) * 1999-10-04 2003-05-28 维昂药品公司 用于将效应分子定向递送至肿瘤的组合物及方法
US6500436B2 (en) * 2000-01-19 2002-12-31 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
EP1570856A3 (en) * 2004-02-26 2005-10-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) A vaccine composition comprising an immunoadjuvant compound consisting of a RHO GTPase family activator
EP1580195A1 (en) * 2004-03-26 2005-09-28 Mutabilis SA Compositions of polypeptides specific to pathogenic ExPEC E. coli strains and their use as vaccines and in immunotherapy
GB0506797D0 (en) * 2005-04-04 2005-05-11 Istituto Superiore Di Sanito Treatment of cognitive and learning impairment

Also Published As

Publication number Publication date
EP1909816A2 (en) 2008-04-16
EP1909816B1 (en) 2010-09-15
DE602006016952D1 (de) 2010-10-28
ATE481107T1 (de) 2010-10-15
WO2007017914A2 (en) 2007-02-15
WO2007017914A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
EA200701918A1 (ru) Белок липокалин
CY1119967T1 (el) Αναστολη πρωτεασης
CY1115535T1 (el) Αναστολεις δραστικοτητας ακτ
DK1737961T3 (da) Modificerede bouganin proteiner, cytotoxiner og fremgangsmåder og anvendelser deraf
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
NO20055838L (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
EA201171494A1 (ru) Миметики белка smac
TW200732349A (en) Anti-OX40L antibodies and methods using same
BRPI0512235A (pt) polipeptìdeos ligadores de antìgenos e seus usos
EA200701528A1 (ru) Новые нутрицевтические композиции
NO20083245L (no) Sykliske antimikrobielle peptider
ATE509949T1 (de) Metastasisch spezifische peptide und ihre diagnostischen und therapeutischen anwendungen
DE50310323D1 (de) Wässrige polyurethanzubereitungen
EA200702353A1 (ru) Белковые гидролизаты, снижающие кровяное давление
DE602006006798D1 (de) Röntgendichte cyanoacrylat-zusammensetzungen
NO20051301L (no) Proteintyrosinforfataseinhibitorer
ITRM20050422A1 (it) Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico.
DE602005025027D1 (de) Quellencodierung und/oder -decodierung
CY1110942T1 (el) Αλας αιθανολαμινης n-(3-μεθοξυ-αιθοξυ-5-μεθυλπυραζιν-2-υλ)-2-(4-[1,3,4-οξαδιαζολο -2-υλ]φαινυλ)πυριδινο-3-σουλφοναμιδιου
EA201100610A1 (ru) Эффективная экспрессия укороченного человеческого белка rnaset2 в e.coli
ITRM20020296A1 (it) Sale di creatina ad aumento potere nutrizionale, antiossidante e terapeutico e composizioni che lo contengono.
EA200971092A1 (ru) Vegf-d мутанты и их применение
BRPI0606169A2 (pt) preparo de rosuvastatina
BRPI0810652A2 (pt) Gene e proteína reguladores de carbono e nitrogênio e modulação dos mesmos.